Hematology NewsComplementary medicine use common among patients on TKIsApril 24, 2019CMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsFDA clears test to monitor residual disease in CMLFebruary 22, 2019CMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsMD Anderson–led alliance seeks to advance leukemia drug developmentJanuary 9, 2019Business of MedicineALLAMLCMLCLL
Hematology TimesEarly switch to dasatinib offers clinical benefit to CML patientsDecember 10, 2018Leukemia, Myelodysplasia, TransplantationCML
Hematology TimesDasatinib re-challenge feasible as 2nd attempt at TKI discontinuationDecember 7, 2018Leukemia, Myelodysplasia, TransplantationCML
Hematology TimesHealth Canada approves two tests for CML patientsNovember 15, 2018Leukemia, Myelodysplasia, TransplantationCML
Hematology NewsWhen is it CMML?October 20, 2018CMLLeukemia, Myelodysplasia, TransplantationMyelodysplastic Syndrome
Hematology TimesFDA issues draft guidance on MRDOctober 16, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLCMLNon-Hodgkin Lymphoma
Hematology NewsOptimizing use of TKIs in chronic leukemiaOctober 15, 2018CMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesOptimizing use of TKIs in CMLOctober 11, 2018Leukemia, Myelodysplasia, TransplantationCML
Hematology TimesAMP publishes report on DNA variants in CMNsAugust 23, 2018CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic SyndromeCML
Hematology TimesFamilial risk of myeloid malignanciesAugust 13, 2018CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic SyndromeCML
